Markus J Riemenschneider
Overview
Explore the profile of Markus J Riemenschneider including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
2920
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brandl B, Steiger M, Kubelt C, Rohrandt C, Zhu Z, Evers M, et al.
Nat Med
. 2025 Feb;
PMID: 40021833
Although the intraoperative molecular diagnosis of the approximately 100 known brain tumor entities described to date has been a goal of neuropathology for the past decade, achieving this within a...
2.
Hinz F, Friedel D, Korshunov A, Ippen F, Bogumil H, Banan R, et al.
Acta Neuropathol
. 2025 Feb;
149(1):12.
PMID: 39899075
IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of...
3.
Engertsberger L, Benesch M, Mynarek M, Tonn S, Obrecht-Sturm D, Perwein T, et al.
Neurooncol Adv
. 2024 Dec;
6(1):vdae179.
PMID: 39713042
Background: Ependymomas of the spinal cord are rare among children and adolescents, and the individual risk of disease progression is difficult to predict. This study aims to evaluate the prognostic...
4.
Araceli T, Fischl A, Haj A, Doenitz C, Stoerr E, Hillberg A, et al.
Front Oncol
. 2024 Dec;
14:1463467.
PMID: 39669367
Purpose: The development of brain metastases (BM) can significantly increase the psycho-oncological burden in cancer patients, requiring timely intervention. In addition, this aspect may negatively affect the course of the...
5.
Wasilewski D, Araceli T, Bischoff P, Fruh A, Ates R, Murad S, et al.
J Neurooncol
. 2024 Dec;
171(3):637-649.
PMID: 39630375
Background: Thyroid Transcription Factor-1 (TTF-1) expression in lung adenocarcinoma (LUAD) has been studied for its prognostic value in early-stage and metastatic disease. Its role in brain metastasis remains unexplored. This...
6.
Gotz L, Ansafi T, Gerken M, Klinkhammer-Schalke M, Fischl A, Riemenschneider M, et al.
Neurooncol Adv
. 2024 Nov;
6(1):vdae170.
PMID: 39493414
Background: Glioblastoma (GB) is the most frequent malignant brain tumor and has a dismal prognosis. In other cancers, antibiotic use has been associated with severity of chemotherapy-induced toxicity and outcome....
7.
Fischl A, Gerken M, Lindberg-Scharf P, Haedenkamp T, Rosengarth K, Hillberg A, et al.
Curr Oncol
. 2024 Oct;
31(10):6155-6170.
PMID: 39451763
(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate...
8.
Zatcepin A, Gnorich J, Rauchmann B, Bartos L, Wagner S, Franzmeier N, et al.
Mol Neurodegener
. 2024 Sep;
19(1):64.
PMID: 39238030
Background: Microglial activation is one hallmark of Alzheimer disease (AD) neuropathology but the impact of the regional interplay of microglia cells in the brain is poorly understood. We hypothesized that...
9.
Bartos L, Quach S, Zenatti V, Kirchleitner S, Blobner J, Wind-Mark K, et al.
Clin Cancer Res
. 2024 Aug;
30(20):4618-4634.
PMID: 39150564
Purpose: Current therapy strategies still provide only limited success in the treatment of glioblastoma, the most frequent primary brain tumor in adults. In addition to the characterization of the tumor...
10.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, et al.
Lancet Oncol
. 2024 Jun;
25(7):922-932.
PMID: 38936379
Background: Neuroblastoma is the most common extracranial solid tumour in children. Relapsed or refractory neuroblastoma is associated with a poor outcome. We assessed the combination of irinotecan-temozolomide and dasatinib-rapamycin (RIST)...